Valganciclovir Hydrochloride

Spécifications

175865-59-5Numéro CAS

641-360-4Numéro CE

[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate;hydrochlorideNom IUPAC

C14H23ClN6O5Formule chimique

390.82 g/molMasse molaire

Valganciclovir hydrochloride; 175865-59-5; Valganciclovir HCl; Valcyte; Valcyt; DTXSID9046784; RS 079070-194; L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, hydrochloride (1:1); 4P3T9QF9NZ; RS-79070-194; NSC-760349; RO 107-9070/194; Ro107-9070/194; RS-079070-194; VALGANCICLOVIR (AS HYDROCHLORIDE); DTXCID7026784; RO-107-9070/194; L-Valine, ester with 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine, monohydrochloride; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester, monohydrochloride; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester, hydrochloride (1:1); L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, monohydrochloride; RefChem:56200; Valganciclovir hydrochloride powder,; Valganciclovir hydrochloride for Oral; MFCD08460118; Valganciclovir (hydrochloride); C14H23ClN6O5; [2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate;hydrochloride; [2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate hydrochloride; [2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate;hydrochloride; NCGC00168779-01; UNII-4P3T9QF9NZ; Valixa; L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, hydrochloride (1:1); L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, monohydrochloride (9CI); RS 079070-194; Ro 107-9070/194; Valcyte; Valganciclovir hydrochloride; Valganciclovir hydrochloride [USAN]; Valcyte (TN); Valganciclovir hydrochloride [USAN:USP]; Valganciclovirhydrochloride; SCHEMBL23225; MLS003876616; SCHEMBL158550; HY-A0032AR; orb1225926; orb1308294; CHEMBL1200454; HY-A0032A; Pharmakon1600-01503870; VALGANCICLOVIR HCL [VANDF]; Tox21_112640; EBC-84175; NSC760349; RG-127; AKOS015963325; AKOS030241609; AC-7501; BS-1015; CCG-213225; CS-1755; FV28652; NSC 760349; TA-9070; Valganciclovir hydrochloride (JAN/USP); GANCICLOVIR VALINATE HYDROCHLORIDE; NCGC00168779-10; VALGANCICLOVIR HYDROCHLORIDE [MI]; 2-((2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)-3-hydroxypropyl L-valinate hydrochloride; 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl Ester L-Valine Hydrochloride; RS-79070; SMR002533167; Valganciclovir (hydrochloride) (Standard); Valganciclovir for system suitability CRS; VALGANCICLOVIR HYDROCHLORIDE [JAN]; VALGANCICLOVIR HYDROCHLORIDE [MART.]; VALGANCICLOVIR HYDROCHLORIDE [VANDF]; CAS-175865-59-5; R-127; V0158; V0244; VALGANCICLOVIR HYDROCHLORIDE [USP-RS]; VALGANCICLOVIR HYDROCHLORIDE [WHO-DD]; Ro-10-79070/194; D03256; F225723; VALGANCICLOVIR HYDROCHLORIDE [ORANGE BOOK]; VALGANCICLOVIR HYDROCHLORIDE [USP MONOGRAPH]; (2S)-2-((2-amino-6-oxo-1H-purin-9(6H)-yl)methoxy)-3-hydroxypropyl 2-amino-3-methylbutanoate hydrochloride; [2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxy-propyl] (2S)-2-amino-3-methyl-butanoate;hydrochloride; 2-[(2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)methoxy]-3-hydroxypropyl L-valinate--hydrogen chloride (1/1); 2-[(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)methoxy]-3-hydroxypropyl (2S)-2-amino-3-methylbutanoate hydrochlorideSynonymes